Algo version: 0.98b
Mega Genomics Limited is listed at the HKSE Exchange
Mega Genomics Limited [6667.HK]
HKSE Sector: Healthcare Industry:Medical Diagnostics Research

Is Mega Genomics Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Mega Genomics Limited 10 years ago, but if you had invested on Tuesday 21st of June 2022 when the price was HKD18.00, you would have made a loss of HKD-10.34 per share or -57.44%

No, the average daily trading liquidity for Mega Genomics Limited is HKD102 219 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Mega Genomics Limited has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 5.13, the company's ability to pay off the debt is good. Mega Genomics Limited has a good net profit margin of 19.97% and should have high tolerances against inflation.

We have calculated the inflation risk for Mega Genomics Limited to be low [0.1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.